| Q33845632 | A Prospective Population Pharmacokinetic Study on Morphine Metabolism in Cancer Patients |
| Q52013911 | A mechanistic approach for the scaling of clearance in children. |
| Q38031400 | Adverse drug reactions. An overview of special considerations in the management of the elderly patient |
| Q36215697 | Age-related changes in hepatic function. Implications for drug therapy |
| Q40627715 | Age-related changes in the gastrointestinal system. Effects on drug therapy |
| Q41217630 | Anaesthesia in the elderly. Special considerations |
| Q34608990 | Clinical pharmacology of analgesic medicines in older people: impact of frailty and cognitive impairment |
| Q42068050 | Comparison of pharmacokinetics of tramadol between young and middle-aged dogs |
| Q79970061 | Controlled-release oxycodone compared with controlled-release morphine in the treatment of cancer pain: a randomized, double-blind, parallel-group study |
| Q51933198 | Development and evaluation of a generic physiologically based pharmacokinetic model for children. |
| Q30828459 | Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly Individuals |
| Q51354299 | Endogenous opioids, placebo response, and pain. |
| Q34768828 | Free drug metabolic clearance in elderly people. |
| Q34357692 | Hepatic drug clearance: the effect of age using indocyanine green as a model compound |
| Q38018026 | Hepatic drug metabolism and aging |
| Q77129794 | Human variability in glucuronidation in relation to uncertainty factors for risk assessment |
| Q40791116 | Individual variation in first-pass metabolism |
| Q34171491 | Pain in nursing home residents: management strategies |
| Q79270512 | Palliative Care in a Long-term Care Setting: A 25-year French Experience |
| Q40920809 | Pharmacokinetic changes in the elderly. Do they contribute to drug abuse and dependence? |
| Q36645757 | Pharmacokinetics of morphine and oxycodone following intravenous administration in elderly patients. |
| Q35625334 | Pharmacological treatments for persistent non-malignant pain in older persons |
| Q39398545 | Pilot study of nasal morphine-chitosan for the relief of breakthrough pain in patients with cancer. |
| Q33729768 | Population Pharmacokinetics of Morphine in Patients With Nonalcoholic Steatohepatitis (NASH) and Healthy Adults. |
| Q77960426 | Population pharmacokinetics of oral morphine and its glucuronides in children receiving morphine as immediate-release liquid or sustained-release tablets for cancer pain |
| Q43239935 | Postoperative analgesia with minidose intrathecal morphine for bipolar hip prosthesis in extremely elderly patients. |
| Q44332303 | Rational opioid dosing in the elderly: dose and dosing interval when initiating opioid therapy |
| Q91368246 | Structural and functional pharmacokinetic analogs for physiologically based pharmacokinetic (PBPK) model evaluation |
| Q28073839 | The Role of Opioid Analgesics in Geriatric Pain Management |